Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125426921 | 12542692 | 1 | I | 20160630 | 20160709 | 20160709 | EXP | GB-AMGEN-GBRSP2016086334 | AMGEN | 63.00 | YR | A | M | Y | 0.00000 | 20160709 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125426921 | 12542692 | 1 | PS | ARANESP | DARBEPOETIN ALFA | 1 | Unknown | 20 MUG, Q2WK | U | 103951 | 20 | UG | SOLUTION FOR INJECTION | QOW | |||||
| 125426921 | 12542692 | 2 | SS | ARANESP | DARBEPOETIN ALFA | 1 | Unknown | 20 MUG, QWK | U | 103951 | 20 | UG | SOLUTION FOR INJECTION | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125426921 | 12542692 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125426921 | 12542692 | HO |
| 125426921 | 12542692 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125426921 | 12542692 | Fall | |
| 125426921 | 12542692 | Hip fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125426921 | 12542692 | 2 | 2016 | 0 |